Coherus Oncology (CHRS) EBT Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) EBT Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | 22.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.07% |
| Dec 31, 2025 | -0.55% |
| Sep 30, 2025 | 6.47% |
| Jun 30, 2025 | 18.21% |
| Mar 31, 2025 | 30.33% |
| Dec 31, 2024 | 42.13% |
| Sep 30, 2024 | -18.94% |
| Jun 30, 2024 | -27.95% |
| Mar 31, 2024 | 10.16% |
| Dec 31, 2023 | -35.30% |
| Sep 30, 2023 | 53.81% |
| Jun 30, 2023 | 14.52% |
| Mar 31, 2023 | 21.18% |
| Dec 31, 2022 | -28.87% |
| Sep 30, 2022 | -124.90% |
| Jun 30, 2022 | -67.73% |
| Mar 31, 2022 | 44.44% |
| Dec 31, 2021 | -524.56% |
| Sep 30, 2021 | -237.03% |
| Jun 30, 2021 | -149.56% |